Paz-Manrique R, Ter LI, Alnadhari I, Qayyum S, Abu Hussein N, Vieira Carneiro B, Sakuma de Oliveira C, Osman Elhag BE, Martines da Costa M, Santos Bittencourt Silva R, Montenegro Carrera RJ, Antunes Kasa M, Toribio Mejia AA, Silva de Paula Rocha R, Faris ME, Barragan Berlanga AJ, Furtado Campos L, Elamin HH, González Mc.Cawley F, Szylewicz S, Hijazi Vega S, Espinoza Briones A, Bartié Rossi G, Camargo CP. Trimodal treatment for localized high risk prostate cancer: A design of a phase II, multi-center, open-label, randomized, parallel-group study to compare the effectiveness and safety of radical prostatectomy, external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT) versus EBRT and ADT for patients with localized high risk prostate cancer. PPCR [Internet]. 2020 May 21 [cited 2024 Sep. 20];6(1):3-8. Available from: https://journal2.teste.pro.br/index.php/ppcrjournal/article/view/94